Updated on 23 July 2013
GSK has admitted that some its senior Chinese executives broke the law, but the company has promised to taking the charges ‘extremely seriously’
Singapore: In what has come as a shocker to the global life sciences industry, Britian's largest drug maker GlaxoSmithKline (GSK) has apologized for ‘breaches of Chinese law'.
Immediately after the arrest of four GSK executives, along with one British private investigator involved in the scandal, Mr Abbas Hussain, head of emerging markets for GSK, apologized to the Chinese authorities. He further promised that the company was taking the charges "extremely seriously".
"Certain senior executives of GSK China who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law. We have zero tolerance for any behaviour of this nature," Mr Hussain said.
Further, GSK's chief executive Dr Andrew Witty is said to be preparing to make a similar statement ahead of the company's half-year result meeting scheduled for July 24, 2013.
This claim comes merely a month after the company said that a four-month internal investigation had found "no evidence of corruption or bribery in our China business".